Precision medecine
Right on target: Medical treatment with accuracy, thanks to genetics
Interview with Dr. Marie-Pierre Dubé, Director of the MHI’s Beaulieu-Saucier Pharmacogenomics Centre - Wednesday 28 June, 2023
As a distinguished researcher and the director of the Beaulieu-Saucier Pharmacogenomics Centre at the Montreal Heart Institute, Dr. Marie-Pierre Dubé pushes the limits of genetics to understand its wide-ranging impact on health. She took the time to explain the basic principles of precision medicine, which allows doctors to personalize patient treatment by analyzing their genetics.
Dreaming of a bright future
Foundation - Friday 14 October, 2022
Interview on the future of cardiovascular medicine with Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute’s Research Centre.
A glimpse at the future of research
Foundation - Friday 26 August, 2022
What will the Institute’s researchers be working on in the coming years? David Rhainds, Deputy Director of the Montreal Heart Institute’s Research Centre, shares an overview of upcoming projects.
Genetic factors and lifestyle habits: can we act in favour of our cardiovascular health despite genetics?
Foundation, in collaboration with Dr. Marie-Pierre Dubé, director of the Beaulieu-Saucier Pharmacogenomics Centre at the Montreal Heart Institute - Wednesday 15 June, 2022
It’s often said that the apple doesn’t fall far from the tree… But what if we could somehow make it roll a bit farther away by having a healthier lifestyle? Dr. Marie-Pierre Dubé, director of the Beaulieu-Saucier Pharmacogenomics Centre at the Montreal Heart Institute, demonstrates the important influence that various modifiable factors have on the genetically determined risk of heart disease.
Patients at the heart of the Institute’s decisions
Foundation - Friday 13 May, 2022
Mélanie La Couture, President and CEO of the Montreal Heart Institute explains how the Institute is positioning itself for the years to come.
Dr. David Busseuil: towards personalized medicine with the Biobank
Foundation - Monday 28 March, 2022
When he first landed in Montreal in 2005 to complete his post-doctorate with Dr. Jean-Claude Tardif at the Montreal Heart Institute, Dr. David Busseuil was still unaware that he would never return to Dijon. Several years later, he is now director of an impressive bank of biological samples and data used for clinical research, the André and France Desmarais Hospital Cohort at the Montreal Heart Institute, also known as the Biobank.
Dr. Sarah Gagliano Taliun: using genetics to keep hearts healthy
Foundation - Monday 24 May, 2021
Born in Ontario, Dr. Sarah Gagliano moved to Montreal in 2020 during a global pandemic to join the Montreal Heart Institute’s research team. This is the story of a bright researcher who loves to take on challenges!
The Gurman brothers: Traveling the world in search of the best treatment
Foundation - Monday 17 May, 2021
Twins Jonathan and Marvin Gurman, both entrepreneurs, recently underwent surgery for aortic valve stenosis. After consulting with various doctors around the world about the most advanced procedures in the field, they finally found the best treatment for them in their home city of Montreal. At the Montreal Heart Institute, they met Dr. Denis Bouchard, a pioneer in minimally invasive surgery. Find out how they learned about this surgical procedure that would have a major impact on their recovery.
The creativity needed to innovate
Foundation, in collaboration with Dr. Marie-Pierre Dubé, Director of the MHI’s Beaulieu-Saucier Pharmacogenomics Centre - Wednesday 17 March, 2021
As Director of the Université de Montréal’s Beaulieu-Saucier Pharmacogenomics Centre at the Montreal Heart Institute for nearly 10 years now, she oversees a team of some 20 experts and wears several hats, including researcher, associate professor and scientific author. She loves her work and enjoys sharing that passion with others.
Colcorona genetic study: better understanding the symptoms of COVID-19
Foundation - Monday 24 August, 2020
The Colcorona genetic study is taking place at the Montreal Heart Institute’s Beaulieu-Saucier Pharmacogenomics Centre and is led by Dr. Marie-Pierre Dubé. This study invited participants who have already accepted to take part in the Colcorona study to voluntarily contribute their DNA. The study of their DNA will help researchers better understand why some patients develop a more severe form of COVID-19.